KALA BIO, Inc.
KALA
株式のランク
#30860
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
株価
$0.75
最終同期: 2026-07-31
時価総額
$14.50M
変化（1日）
2.78%
変化（1年）
-98.84%
国
US
取引 KALA BIO, Inc. (KALA)
カテゴリー
Healthcare
の時価総額 KALA BIO, Inc.(KALA)
時価総額: $14.50M
October 2026時点で、KALA BIO, Inc. の時価総額は $14.50M です。これは、当社のデータによると、KALA BIO, Inc. が世界で30860th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
KALA BIO, Inc. の時価総額の履歴（2018 から 2026 まで）
KALA最も人気のあるトップ5と比較stocks
